|
|
|
| Dance Pharma and Aerogen to develop proprietary inhaled insulin device |
|
|
|
| News - Nanomedicine and Drug Delivery News | |
| Wednesday, 12 January 2011 | |
|
Dance Pharma and Aerogen Ltd. Announced that both companies will develop Dance's inhaled insulin product in a novel aerosol device based on Aerogen's proprietary OnQ™ Aerosol Generator technology, .
Aerogen has granted Dance an exclusive worldwide license to their aerosol technology for insulin delivery. Other terms of the agreement were not disclosed.
Source: Dance Pharmaceuticals |
|
| < Prev | Next > |
|---|